GOSS · Gossamer Bio, Inc.
$0.14
-0.03 (-17.06%)
At close · Jul 20
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company’s existing cash and cash equivalents are not sufficient to fund operating plans for at least one year from the issuance date of these financial statements. Accordingly, these conditions raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$33.09M
Shares
234.70M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Faheem Hasnain | CEO | $2,300,455 |
| Bryan Giraudo | COO | $1,253,431 |
| Robert Smith | Chief Commercial Officer | $1,180,744 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Faheem Hasnain | CEO | $2,005,432 |
| Bryan Giraudo | COO | $1,171,904 |
| Richard Aranda | Senior Vice President | $1,065,055 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Faheem Hasnain | CEO | $2,095,988 |
| Robert Smith | Chief Commercial Officer | $1,330,845 |
| Bryan Giraudo | COO | $1,287,882 |
| Richard Aranda | Senior Vice President | $1,032,753 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Faheem Hasnain | CEO | $7,262,410 |
| Bryan Giraudo | COO | $3,268,699 |
| Richard Aranda | Senior Vice President | $2,481,944 |
| Chief Commercial | Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Faheem Hasnain | CEO | $4,751,620 |
| Bryan Giraudo | COO | $2,825,437 |
| Christian Waage | Executive Vice President, Technical Operations and Administration | $1,650,988 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Sheila Gujrathi | CEO | $7,213,742 |
| Bryan Giraudo | COO | $2,014,958 |
| Luisa Salter-Cid | Chief Scientific Officer | $1,994,828 |
| Christian Waage | Executive Vice President, Technical Operations and Administration | $1,990,351 |
| Jakob Dupont | Executive Vice President and Global Head of Research and Development | $1,642,287 |
| Faheem Hasnain | CEO | $598,771 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Sheila Gujrathi | CEO | $6,245,606 |
| Bryan Giraudo | COO | $2,647,282 |
| Chief Scientific | Officer | $2,258,884 |
| Luisa Salter-Cid | Chief Scientific Officer | $2,258,884 |
| Christian Waage | Executive Vice President, Technical Operations and Administration | $2,060,653 |
| Jakob Dupont | Executive Vice President and Global Head of Research and Development | $1,637,440 |
| Faheem Hasnain | CEO | $982,222 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Sheila Gujrathi | CEO | $18,709,912 |
| Faheem Hasnain | CEO | $18,709,912 |
| Jakob Dupont | Executive Vice President and Global Head of Research and Development | $3,530,454 |
| Bryan Giraudo | CFO | $2,192,515 |
| Chief Scientific | Officer | $1,858,327 |
| Christian Waage | General Counsel | $867,304 |
Key facts
CIK
1728117
CUSIP
38341P102
13F (30d)
15 filings
15 filers
Visit website
Investor relations